Akzo Nobel appoints new manager for its business unit Intervet

21 March 2001

Ruurd Stolp, who holds a PhD in Veterinary Medicine from University of Utrecht, joined Intervet in 1989 as Head, Microbiological Quality Control. Following his return in 1996 from a post with Intervet’s US business, he was appointed to the Board of Intervet. He is currently Vice-President in charge of Manufacturing, Logistics, Quality Control and Technical Affairs.   

As Mr. Stolp receives the reins of Intervet in summer 2002, his predecessor, Toon Wilderbeek (51), the current General Manager, can look back to a successful period of developing Intervet from a specialized vaccine manufacturer to one of the world’s three leading companies in animal health. A graduate in Veterinary Medicine from the University of Utrecht, Mr. Wilderbeek worked in Tunisia from 1976 to 1980 as a field officer for the Dutch Ministry of Development Aid. He joined Intervet in 1980 as an assistant in the Veterinary Service department. Subsequently, he held various management functions before becoming Manager R&D/Manufacturing and a member of Intervet’s Board of Management in 1991. In 1994 he was appointed General Manager of Intervet International.   

 -------------- Note for the editor   

Intervet, a business unit of Akzo Nobel, headquartered in Boxmeer, the Netherlands, with sales in 2001 of EUR 1,096 million, is focused on the research and development, manufacturing and marketing of veterinary products. Products include vaccines for the prevention of infectious diseases, anti-infectives, anti-parasitics, feed additives and products for fertility management. All of these products are intended for use in a variety of animal species, including poultry, pigs, cattle, sheep, goats, horses, fish and companion animals. Intervet operates globally through its own marketing organizations. The company currently employs around 5,000 people.   

Internet: http://www.intervet.com/   

Akzo Nobel, based in the Netherlands, serves customers throughout the world with healthcare products, coatings and chemicals. Consolidated sales for 2001 totaled EUR 14 billion. The Company currently employs approximately 66,000 people in   

80 countries. Financial results for the first quarter will be published on April 23, 2002.   

Internet: http://www.akzonobel.com   

 For further information please contact:   

Sabine Schueller, DVM, PhD 
Communications & Public Affairs 
Intervet International bv
Tel: +31 (0)485-587085
Fax: +31 (0)485-587083
communications@intervet.com